Development and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells

Single-walled carbon nanotubes (SWNTs) have been identified as an efficient drug carrier. Here a controlled drug-delivery system based on SWNTs coated with doxorubicin (DOX) through hydrazone bonds was developed, because the hydrazone bond is more sensitive to tumor microenvironments than other covalent linkers. The SWNTs were firstly stabilized with polyethylene glycol (H2N-PEG-NH2). Hydrazinobenzoic acid (HBA) was then covalently attached on SWNTs via carbodiimide-activated coupling reaction to form hydrazine-modified SWNTs. The anticancer drug DOX was conjugated to the HBA segments of SWNT using hydrazine as the linker. The resulting hydrazone bonds formed between the DOX molecules and the HBA segments of SWNTs are acid cleavable, thereby providing a strong pH-responsive drug release, which may facilitate effective DOX release near the acidic tumor microenvironment and thus reduce its overall systemic toxicity. The DOX-loaded SWNTs were efficiently taken up by HepG2 tumor cells, and DOX was released intracellularly, as revealed by MTT assay and confocal microscope observations. Compared with SWNT-DOX conjugate formed by supramolecular interaction, the SWNT-HBA-DOX featured high weight loading and prolonged release of DOX, and thus improved its cytotoxicity against cancer cells. This study suggests that while SWNTs have great potential as a drug carrier, the efficient formulation strategy requires further study.

[1]  S. Gong,et al.  Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers , 2009 .

[2]  Xunbin Wei,et al.  pH‐Activated Near‐Infrared Fluorescence Nanoprobe Imaging Tumors by Sensing the Acidic Microenvironment , 2010 .

[3]  Zhuang Liu,et al.  Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. , 2005, Journal of the American Chemical Society.

[4]  K. Ulbrich,et al.  New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Weibo Cai,et al.  Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.

[6]  Xiaoke Zhang,et al.  Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. , 2009, Biomaterials.

[7]  M. Foldvari,et al.  Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. , 2008, Nanomedicine : nanotechnology, biology, and medicine.

[8]  Zhuang Liu,et al.  Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. , 2009, Angewandte Chemie.

[9]  Shuk Han Cheng,et al.  Nanotherapeutics in angiogenesis: synthesis and in vivo assessment of drug efficacy and biocompatibility in zebrafish embryos , 2011, International journal of nanomedicine.

[10]  J. Cummings,et al.  DNA topoisomerase I and II as targets for rational design of new anticancer drugs. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  K. Leong,et al.  Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. , 2005, Angewandte Chemie.

[12]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[13]  Maurizio Prato,et al.  Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. , 2008, Chemical communications.

[14]  M. Prato,et al.  Functionalized carbon nanotubes for plasmid DNA gene delivery. , 2004, Angewandte Chemie.

[15]  Srikanth Pilla,et al.  Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. , 2009, Biomaterials.

[16]  K. Ulbrich,et al.  Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bond. , 2010, Molecular pharmaceutics.

[17]  S. Gong,et al.  Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy. , 2010, Bioconjugate chemistry.

[18]  H. Dai,et al.  Carbon nanotubes as intracellular protein transporters: generality and biological functionality. , 2005, Journal of the American Chemical Society.

[19]  H. Dai,et al.  Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery , 2009, Nano research.

[20]  Dan Ding,et al.  Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity. , 2009, ACS nano.

[21]  D. Gewirtz,et al.  Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. , 1994, Molecular pharmacology.

[22]  Hongjie Dai,et al.  Supramolecular Chemistry on Water- Soluble Carbon Nanotubes for Drug Loading and Delivery , 2007 .

[23]  Amit Jain,et al.  Carbohydrate-conjugated multiwalled carbon nanotubes: development and characterization. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[24]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[25]  Ya‐Ping Sun,et al.  Reversible accumulation of PEGylated single-walled carbon nanotubes in the mammalian nucleus. , 2008, ACS nano.

[26]  Maurizio Prato,et al.  Double functionalization of carbon nanotubes for multimodal drug delivery. , 2006, Chemical communications.

[27]  Shiladitya Sengupta,et al.  Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma , 2010, Nanotechnology.

[28]  Stanislaus S. Wong,et al.  Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. , 2008, Journal of the American Chemical Society.

[29]  M. Prato,et al.  Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. , 2007, Nature nanotechnology.

[30]  Kostas Kostarelos,et al.  The long and short of carbon nanotube toxicity , 2008, Nature Biotechnology.

[31]  K. Ulbrich,et al.  Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[32]  H. Dai,et al.  Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. , 2008, Journal of the American Chemical Society.

[33]  M. Foldvari,et al.  Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties. , 2008, Nanomedicine : nanotechnology, biology, and medicine.